Skandinaviska Enskilda Banken (SEB)
PRAH

Skandinaviska Enskilda Banken (SEB)’s PRA Health Sciences, Inc. PRAH Stock Holding History

Skandinaviska Enskilda Banken (SEB)’s Portfolio PRAH Stock Details PRAH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-17,668
Closed -$2.92M – 1131
2021
Q2 		$2.92M Buy
17,668
+8,000
+83% +$1.34M 0.02% 561
2021
Q1 		$1.48M Sell
9,668
-14,332
-60% -$1.95M 0.01% 741
2020
Q4 		$3.01M Sell
24,000
-2,300
-9% -$257K 0.02% 509
2020
Q3 		$2.67M Sell
26,300
-3,300
-11% -$336K 0.02% 487
2020
Q2 		$2.88M Buy
29,600
+400
+1% +$37.2K 0.02% 465
2020
Q1 		$2.42M Sell
29,200
-10,800
-27% -$1.05M 0.02% 426
2019
Q4 		$4.45M Buy
40,000
+200
+0.5% +$20.6K 0.04% 370
2019
Q3 		$3.95M Sell
39,800
-4,900
-11% -$487K 0.03% 370
2019
Q2 		$4.43M Sell
44,700
-7,400
-14% -$706K 0.04% 334
2019
Q1 		$5.75M Hold
52,100
– – 0.05% 271
2018
Q4 		$4.79M Sell
52,100
-5,700
-10% -$577K 0.04% 283
2018
Q3 		$6.37M Buy
57,800
+18,300
+46% +$1.91M 0.05% 254
2018
Q2 		$3.69M Sell
39,500
-3,500
-8% -$301K 0.03% 319
2018
Q1 		$3.57M Sell
43,000
-23,000
-35% -$2.04M 0.03% 277
2017
Q4 		$6.01M Buy
66,000
+5,600
+9% +$466K 0.05% 258
2017
Q3 		$4.6M Sell
60,400
-1,800
-3% -$136K 0.04% 304
2017
Q2 		$4.67M Sell
62,200
-14,300
-19% -$991K 0.04% 306
2017
Q1 		$4.99M Sell
76,500
-16,100
-17% -$948K 0.05% 278
2016
Q4 		$5.1M Sell
92,600
-19,400
-17% -$1.06M 0.06% 231
2016
Q3 		$6.33M Sell
112,000
-20,700
-16% -$1.02M 0.07% 209
2016
Q2 		$5.54M Buy
132,700
+9,200
+7% +$424K 0.06% 226
2016
Q1 		$5.28M Buy
+123,500
New +$5.22M 0.06% 236

Other funds holding PRAH

BCI
Brinker Capital Investments Berwyn, Pennsylvania $11.7B AUM 21.33% 1-Year Est. Return

Skandinaviska Enskilda Banken (SEB)'s PRAH Position: Q3 2021 in Review

Skandinaviska Enskilda Banken (SEB) sold out of PRA Health Sciences, Inc. (PRAH) in Q3 2021, closing a stake of 17,668 shares — an estimated $2.92M sold.

Skandinaviska Enskilda Banken (SEB) first reported a position in PRAH in Q1 2016 and held it in 22 quarters. The position peaked at $6.37M in Q3 2018. 1 fund tracked by Wall St. Rank holds PRAH as of Q3 2021.

  • Skandinaviska Enskilda Banken (SEB) reported no remaining PRA Health Sciences, Inc. position as of Q3 2021 after selling out during the quarter.
  • Skandinaviska Enskilda Banken (SEB) sold 17,668 PRA Health Sciences, Inc. shares in Q3 2021, an estimated $2.92M.
  • Skandinaviska Enskilda Banken (SEB) first reported a position in PRA Health Sciences, Inc. in Q1 2016 and held it in 22 quarters.
  • Skandinaviska Enskilda Banken (SEB)'s PRA Health Sciences, Inc. position peaked at $6.37M in Q3 2018.
  • 1 fund tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q3 2021.

Based on Skandinaviska Enskilda Banken (SEB)'s 13F filing for Q3 2021, filed 10 Nov 2021.